Production (Stage)
PDS Biotechnology Corporation
PDSB
$1.69
$0.138.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.00% | -26.29% | -8.29% | -4.77% | 2.20% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 21.39% | 34.89% | -8.00% | -10.94% | -26.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -38.17% | -23.71% | -8.28% | -5.03% | 1.05% |
|
|
|||||
| Total Current Assets | -38.17% | -23.71% | -8.28% | -5.03% | 1.05% |
| Net Property, Plant & Equipment | -9.83% | -9.19% | -8.61% | -17.06% | -32.55% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -31.85% | -23.63% | -8.28% | -5.11% | 0.81% |
|
|
|||||
| Total Accounts Payable | -52.35% | -75.87% | -75.76% | -26.33% | 189.60% |
| Total Accrued Expenses | 66.06% | 17.18% | 20.01% | -42.33% | -7.76% |
| Short-term Debt | 71.43% | 200.00% | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 4.38% | 9.50% | 9.54% | -48.32% | -71.32% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.25% | 25.36% | 100.36% | 98.31% | 264.78% |
|
|
|||||
| Total Current Liabilities | 21.25% | 25.36% | 100.36% | 98.31% | 264.78% |
| Long-Term Debt | -61.85% | -52.81% | -48.61% | -40.61% | -28.05% |
| Short-term Debt | 71.43% | 200.00% | -- | -- | -- |
| Capital Leases | -54.99% | -49.67% | -43.45% | -38.55% | -34.54% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -22.49% | -20.76% | -6.89% | -5.53% | 15.98% |
|
|
|||||
| Common Stock & APIC | 10.75% | 17.87% | 24.08% | 25.23% | 26.31% |
| Retained Earnings | -22.89% | -26.03% | -30.36% | -33.14% | -39.46% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -39.86% | -27.27% | -10.14% | -4.70% | -9.33% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -39.86% | -27.27% | -10.14% | -4.70% | -9.33% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -39.86% | -27.27% | -10.14% | -4.70% | -9.33% |
|
|
|||||